Article Text

Download PDFPDF
Atorvastatin was at least as effective as PTCA for reducing ischaemic events in patients with stable coronary artery disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Source of funding: Parke-Davis Pharmaceutical Research.

  • For correspondence: Dr B Pitt, Division of Cardiology, University of Michigan Medical Center, 3910 Taubman, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0366, USA. FAX 734-936-5256.

  • * See glossary.